Synopsis: In Vasa Denticity Limited, ace investor Mukul Mahavir Agrawal increased his stake during the December 2025 quarter, while Ashish Kacholia trimmed his shareholding, indicating contrasting investment strategies.
This Healthcare Stock, engaged in marketing and distributing dental consumables, instruments, equipment, and accessories via Dentalkart.com for clinics across India, is in focus after Mukual Agrwal increased his stake and Ashish Kacholia decreased his stake in Q3 FY26.
With a market capitalization of Rs. 1,055.81 crore, the shares of Vasa Denticity Limited were currently trading at Rs. 609 per equity share, rising nearly 0.50 percent from its previous day’s close price of Rs. 606.
What is the News?
Vasa Denticity Limited engages in marketing and distribution of dental consumables, instruments, equipment, and accessories through its online portal Dentalkart.com. In this stock, Mukul Agrawal has increased his stake, while Ashish Kacholia has decreased his stake in the December quarter of 2025.
In the shareholding pattern, Vasa Denticity Limited had a majority stake held by the promoters at 60.75 percent, foreign institutional investors at 7.50 percent, domestic institutional investors at 0.87 percent, and the public at 30.88 percent of December Quarter of 2025.
Ace Investor Mukul Mahavir Agrawal is a well-known equity investor in the Indian stock market. As per the latest corporate shareholding disclosures, he publicly holds stakes in around 70 listed companies, with a total portfolio value of over Rs. 6,465.4 crore, highlighting his strong presence across multiple sectors.
In a recent quarter update, Mukul Mahavir Agrawal increased his holding in Vasa Denticity Limited from 2 percent in September 2025 to 2.36 percent in December 2025, marking a 0.36 percentage-point increase in his stake. His current holding is valued at Rs. 24.6 crores and consists of 4.10 lakh shares in the company.
Similarly, Ace investor Ashish Kacholia is a prominent equity market participant in India. According to the latest corporate shareholding disclosures, he holds public stakes in nearly 49 listed companies, with a combined portfolio value exceeding Rs. 2,481 crore.
In a recent quarter update, Ashish Kacholia decreased his holding in Vasa Denticity Limited from 4 percent in September 2025 to 3.51 percent in December 2025, marking a 0.49 percentage-point reduction in his stake.
Company Overview:
Vasa Denticity Limited serves as a leading supplier of dental products, instruments, equipment, and consumables tailored for clinics, hospitals, and practitioners across India. The company delivers comprehensive dental commerce and technology platforms designed to meet diverse oral-care needs for professionals.
The company distributes an extensive range of items, including nasal drops, local anesthesia, analgesics, vitamins, supplements, and antibiotics from prominent brands. Through subsidiaries like Waldent Innovations Private Limited and Smileworks Private Limited, Vasa engages in manufacturing, processing, exporting, importing, distributing, and trading surgical instruments, diagnostic equipment, and medical devices.
Recent Quarter Results:
Coming into financial highlights, Vasa Denticity Limited’s revenue has increased from Rs. 59.39 crore in Q2 FY25 to Rs. 72.94 crore in Q2 FY26, which has grown by 22.82 percent. The net profit has decreased by 13.59 percent from Rs. 5.37 crore in Q2 FY25 to Rs. 4.64 crore in Q2 FY26. Vasa Denticity Limited’s Standalone revenue and net profit have grown at a CAGR of 47.88 percent and 50.37 percent, respectively, over the last three years.
In terms of return ratios, the company’s ROCE and ROE stand at 22.9 percent and 16.9 percent, respectively. Vasa Denticity Limited has an earnings per share (EPS) of Rs. 9.33, and it’s a debt-free company
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
